Silk Road Medical Q2 EPS $(0.42) Misses $(0.38) Estimate, Sales $51.24M Beat $49.60M Estimate
Portfolio Pulse from Benzinga Newsdesk
Silk Road Medical (NASDAQ:SILK) reported Q2 earnings per share (EPS) of $(0.42), missing the analyst estimate of $(0.38) by 10.53%. However, the company reported sales of $51.24 million, beating the estimate of $49.60 million by 3.31%.
August 07, 2024 | 9:12 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Silk Road Medical reported a Q2 EPS of $(0.42), missing the analyst estimate of $(0.38) by 10.53%. However, the company reported sales of $51.24 million, beating the estimate of $49.60 million by 3.31%.
The mixed results, with an EPS miss but a sales beat, are likely to have a neutral short-term impact on the stock price. Investors may weigh the negative EPS against the positive sales performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100